Back

Smoking increases the risk of COVID-19 positivity, while Never-smoking reduces the risk

barasa, s.; Kiage-Mokaya, J.; Friedlander, M.; Cruz-Madrid, K.

2020-12-02 respiratory medicine
10.1101/2020.11.30.20241380 medRxiv
Show abstract

IntroductionDoes smoking decrease the risk of testing positive for COVID-19 because the never-smokers (84%) prevalence is high and the current-smokers prevalence is low among COVID-19 positive patients? 1,2,3,4,5,6 We sought to determine whether never smoking increases the risk of COVID-19 positivity among the 50 to 69-year old patients because they are more likely to test positive for COVID-19.7 MethodWe conducted a retrospective chart review of COVID-19 Polymerase chain reaction, in-hospital tested [≥]18-year-old patients. A Poisson regression analysis stratified into never-smokers and history of smoking (current + former smokers) was conducted. Results277 COVID-19 negative and 117 COVID-19 positive patients charts with a never-smokers prevalence of 42.32% and 54% respectively were analyzed. The never-smokers prevalence was 54%, 20-39-years; 61 %, 40 -49-years; 41%, 50 - 69-years; and 43%, 70 - 100-years. The 40-49-year-old current and former smokers were more likely to test positive for COVID-19 [1.309 (1.047 - 1.635)], unlike the 40-49-year-old never-smokers [0.976 (0.890-1.071)] who had a lower risk. Regardless of their smoking status, males [1.084(1.021 - 1.151)] and the 50-69-year-old patients [1.082 (1.014 -1.154)] were more likely to test positive for COVID-19, while end stage renal disease [0.908(0.843-0.978)] and non-COVID-19 respiratory viral illness [0.907 (0.863 - 0.953)] patients had a lower risk of COVID-19 positivity. Heart failure [0.907 (0.830 - 0.991)], chronic obstructive pulmonary disease (COPD) [0.842 (0.745 - 0.952)] and Parkinsons disease [0.823 (0.708 - 0.957)] never-smokers were less likely to test positive for COVID-19. ConclusionThis is the first study to show that smoking increases the risk of COVID-19 positivity among the 40-49-year-old patients, while not smoking reduces the risk of COVID-19 positivity among the heart failure, COPD and Parkinsons disease patients. This study emphasizes that COVID-19 positivity risk is not reduced by smoking and not increased by not smoking.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.